PIEZO1 and cancer: The observation that genetic deletion of Piezo1 in myeloid cells protected against cancer suggests that Piezo1 could be a target for suppressing inflammation in different organs, including GI tract cancers (74), although the potential for immunosuppressive side effects of such a strategy is unknown.